Table 2.
Groups | Sex | No. of tumor- |
10 days after HCaf challenge |
15 days after HCaF challenge |
|||
Size of tumor (mm3) | Inhibition rate (%) | Size of tumor (mm3) | Inhibition rate (%) | ||||
bearing mice | |||||||
HSP70 | 300 μg/kg | Female | 2 | 0.88bc | 97.0ac | 6.66bd | 98.5ad |
Male | 6 | 61.98bd | 80.2bd | 384.77bc | 83.2bc | ||
600 μg/kg | Female | 1 | 0.45 | 98.4 | 5.74 | ||
Male | 6 | 64.49b | 79.4bd | 515.10bc | 77.6bc | ||
S-HCaF | Female | 5 | 3.09bc | 89.2bc | 10.21bc | 97.7bc | |
Male | 6 | 24.27bd | 92.2bd | 501.55b | 78.2bd | ||
S-HC | Female | 6 | 30.00 | -4.5 | 402.17 | 8.2 | |
Male | 6 | 204.89 | 34.5 | 1554.30 | 32.3 | ||
PBS | Female | 6 | 28.70 | 438.17 | |||
Male | 6 | 312.83 | 2295.52 |
P < 0.05, vs PBS;
P < 0.01, vs PBS;
P < 0.01, vs S-HC;
P < 0.05, vs S-HC. Inhibition rate (%)=1 - [(Tumor size of experimental group/Tumor size of control group(PBS)) × 100%]